306 related articles for article (PubMed ID: 37013511)
21. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
[TBL] [Abstract][Full Text] [Related]
22. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
23. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
24. Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.
Sun J; Zhang X; Wu F; Zhu B; Xie H
BMC Urol; 2024 Apr; 24(1):84. PubMed ID: 38600527
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC).
Xu H; Wang X; Zhu F; Guo S; Chao Z; Cao C; Lu Z; Zhu H; Wang M; Zhu F; Yang J; Zeng R; Yao Y
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792963
[No Abstract] [Full Text] [Related]
26. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
27. The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma.
Xie D; Wang S; Jiang B; Li G; Wu G
Aging (Albany NY); 2024 Jan; 16(1):246-266. PubMed ID: 38180750
[TBL] [Abstract][Full Text] [Related]
28. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
[TBL] [Abstract][Full Text] [Related]
29.
Ke P; Bao X; Liu C; Zhou B; Huo M; Chen Y; Wang X; Wu D; Ma X; Liu D; Chen S
Transl Cancer Res; 2022 Oct; 11(10):3491-3505. PubMed ID: 36388050
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
[TBL] [Abstract][Full Text] [Related]
31. N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
Guo T; Duan H; Chen J; Liu J; Othmane B; Hu J; Li H; Zu X
Front Oncol; 2021; 11():718644. PubMed ID: 34497769
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of LAG3 immune signature and identification of a LAG3-related genes prognostic signature in kidney renal clear cell carcinoma.
Li J; Liu C; Su H; Dong H; Wang Z; Wang Y; Zhao P; Zhang C; Zhao Y; Ma X
Aging (Albany NY); 2024 Jan; 16(3):2161-2180. PubMed ID: 38277212
[TBL] [Abstract][Full Text] [Related]
33. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
Liu S; Yu Y; Wang Y; Zhu B; Han B
Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
35. PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.
Qin C; Liu S; Zhou S; Wang Q; Xia X; Hu J; Yuan X; Wang Z; Yu Y; Ma D
Front Immunol; 2023; 14():1114572. PubMed ID: 37063922
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
38. The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma.
Zhang S; Liu Z; Xiao M; Liu H
Transl Cancer Res; 2021 Jun; 10(6):2678-2693. PubMed ID: 35116580
[TBL] [Abstract][Full Text] [Related]
39. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
40. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
Weng J; Huang Z; Li Q; Huang Y; Chen S
Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]